Please turn JavaScript on
STAT icon

STAT

Subscribe to STAT’s news feed.

Click on “Follow” and decide if you want to get news from STAT via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to STAT comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from STAT which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: STAT | Reporting from the frontiers of health and medicine

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  9.87 / day

Message History

WASHINGTON — The Trump administration did not overhaul the childhood vaccine schedule or flip the food pyramid until Heidi Overton, deputy director of domestic policy for the White House, had her say. 

While health secretary Robert F. Kennedy Jr. has been the public face of the Make America Healthy Again movement, Overton has been the top health policymaker behind t...


Read full story

WASHINGTON — Erica Schwartz, the new director of the Centers for Disease Control and Prevention, told agency staff on Wednesday that she was prepared to disagree with administration leaders and sought to empower others to do the same, according to a recording of the meeting obtained by STAT.

During her first all-hands address on Wednesday, Schwartz identified three ...


Read full story

Dear Readers,

When we launched STAT more than a decade ago, our mission statement promised that we would deliver “trusted, tough-minded journalism.” Little did we know that trust would be at the core of everything we do. 


Read full story

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’re sending the newsletter a bit early today since we’ve got some breaking news for you — plus a new FDA commissioner no...


Read full story

A medicine from Regeneron Pharmaceuticals for an ultra-rare disease that causes bone to grow where it shouldn’t won approval on Wednesday, the capstone of a three-decade effort.

The hope is that the new medicine, called P...


Read full story